JA2 WP5 – Applying the HTA Core Model for Rapid Assessment for national adaptation and reporting

• To test the capacity of national HTA bodies to produce structured core HTA information (full core/rapid HTAs) together and apply it in national context (including collection of data on costs and overall efficiency of the production in the network)
• To implement, pilot and further develop models and tools as well as production processes to support collaborative production of core HTA information with reinforced secretariat and coordination function
• To develop and test a methodological basis for European cooperation on HTA including guidelines for distinct methodological issues and quality improvement of evidence generation for HTA.

• Pilot rapid assessments

• Coordinating and supporting the joint pilots of rapid assessments of pharmaceuticals (strand A) and non-pharmaceuticals (strand B), on a quarterly basis during the first year
• Final rapid model for relative effectiveness of pharmaceuticals and rapid core model for non-pharmaceutical interventions (in cooperation with WP7).

Lead Partner

Co-Lead Partner

Associated Partners

Collaborating partners